Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,726 | -113,265 | -36,538 | -19,309 | -7,671 |
| Depreciation Amortization | 1,076 | 76,528 | 3,071 | 2,043 | 1,016 |
| Accounts receivable | 1,595 | -1,817 | 342 | 595 | -1,922 |
| Accounts payable and accrued liabilities | 560 | 5,643 | 1,180 | 2,456 | 1,294 |
| Other Working Capital | -56 | -8,356 | 1,976 | 3,526 | -249 |
| Other Operating Activity | -239 | -273 | 3,030 | 43 | 1,034 |
| Operating Cash Flow | $-20,790 | $-41,540 | $-26,939 | $-10,646 | $-6,498 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -133 | -1,604 | -449 | -36 | -41 |
| Other Investing Activity | 0 | -550 | -250 | 0 | 0 |
| Investing Cash Flow | $-133 | $-2,154 | $-699 | $-36 | $-41 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 55,578 | 23,417 | 23,417 | 23,417 | 5,030 |
| Debt Repayment | -19,814 | -13,067 | -12,747 | -12,365 | -1,258 |
| Common Stock Issued | 47,581 | 44,802 | 46,080 | 42 | 42 |
| Other Financing Activity | 0 | 0 | -1,637 | -237 | -135 |
| Financing Cash Flow | $83,345 | $55,152 | $55,113 | $10,857 | $3,679 |
| Exchange Rate Effect | -37 | 1,124 | 138 | 213 | 32 |
| Beginning Cash Position | 17,966 | 5,384 | 5,384 | 5,384 | 5,384 |
| End Cash Position | 80,351 | 17,966 | 32,997 | 5,772 | 2,556 |
| Net Cash Flow | $62,385 | $12,582 | $27,613 | $388 | $-2,828 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,790 | -41,540 | -26,939 | -10,646 | -6,498 |
| Capital Expenditure | -133 | -1,604 | -449 | -36 | -41 |
| Free Cash Flow | -20,923 | -43,144 | -27,388 | -10,682 | -6,539 |